The Triforce of AR Transcriptional Regulation:TFs, Cofactors, and Chromatin
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The overall aim of this thesis is to better understand the biology of the AR, and how it is influenced by the action of cofactors. Additionally, we aim to dissect which hierarchies in protein complex assembly are present in FOXA1/AR co-bound genomic regions. Chapter 2 of this thesis introduces the basics of AR biology alongside the implications of AR in prostate cancer. Especially the alterations in AR chromatin binding across the genome in different disease stages are a focus point of this chapter. As an outlook, we also introduce the possibility to target AR cofactors rather than the AR directly. In Chapter 3, we review the effect of different tripartite motif (TRIM) protein family members on different hormone dependent cancers including breast, prostate, ovarian and endometrial cancer. Interestingly, some TRIM proteins show clear association with SHR biology, while others act independent of these hormone-dependent transcription factors. The main focus of SHR function is associated with transcriptional changes but several studies have shown that they are also involved in DNA damage biology. In Chapter 4, we review the latest developments of this research field, integrating the individual reports into functional and interpretable models. Interestingly, SHRs interact with DNA damage repair pathways in two ways. On one hand, SHRs can regulate proteins involved in DNA damage on transcriptional levels and on the other hand SHRs can also physically interact with components of the DNA damage machinery. Additionally, the induction of transcriptional stress by SHR activation and subsequent DNA damage, further complicate the interplay of SHRs and DNA damage repair. To study the composition of the androgen receptor protein complex, as well as alterations of the cellular proteome after hormonal stimulation, we made use of methods based on mass spectrometry. To analyze this data in a uniform and user-friendly way, we developed a R-package called DEprot in Chapter 5. The package introduces a new two-step imputation strategy for missing data; a known limitation in mass spectrometry. Additionally, the package provides a user friendly and adaptable tool for the analysis of label free quantification (LFQ) data from imputation, normalization and quality control to differential and enrichment analysis as well as visualization of the data. In Chapter 6, we comprehensively charted the AR transcription complex composition, and identified a core interactome of around 100 shared AR-binding proteins across different prostate cancer cell line models using rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME)56. For one commonly shared AR interactor, TRIM33, we characterized its impact on AR activity. Using CRISPR/Cas9 mediated knockouts together with multiomic data streams (ChIP-seq, RNA-seq, whole cell proteomics, RIME), we could show that TRIM33 affects a subset of AR target genes, which coincides with a reduction of the gene body histone mark H2BK120ub, which is associated with transcriptional activity.AR is not only involved in prostate cancer, but is also expressed in estrogen receptor (ER)-positive breast cancer where it serves as tumor suppressor57,58. In Chapter 7 we describe how AR can have different transcriptional activities in these two different tissues. We hypothesized, that cofactors are crucial in determining AR tissue specific activities. Integrating several publicly available datasets (STARR-seq, RNA-seq, ChIP-seq) with newly generated RIME data, we identify HOXB13 and GATA2 as prostate specific cofactors and HOXC11 and GATA3 as breast specific interactors. Introduction of prostate specific cofactors in breast cancer cells did not affect DNA accessibility but did result in limited AR reprogramming and detection of prostate specific proteins in breast cancer cell line models, implying that tissue selective gene activity is in part regulated by specific expression of AR-interacting TFs. In Chapter 8, we applied time course RIME experiments for the AR pioneering factor FOXA1 with different timings following AR stimulation. The aim was to unbiasedly characterize the protein complex hierarchy during AR transcriptional regulation. We leveraged modelling and clustering of the data to identify a distinct order of complex recruitments over the activation time-course. Furthermore, we integrated time course ATAC-seq and ChIP-seq data to further dissect the interaction dynamics based on genomic locations. Lastly, we could show that genetic and chemical depletion of specific AR interacting proteins revealed dependencies between complexes and altered protein recruitment dynamics. Finally, Chapter 9 contains a general discussion about our findings on the fundamental activity of AR as an enhancer acting TF. The focus especially lies on the role of cofactors in AR biology and how they shape AR activity.
Fields of Study & Subjects
Prostate Cancer Treatment and Research
Chromatin Remodeling and Cancer
Genomics and Chromatin Dynamics
Publication details
- Journal / source
- TU/e Research Portal
- Publication date
- 20 March 2026
- Language
- EN